Stay updated with breaking news from Stefan Braam. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MONT-SAINT-GUIBERT, Belgium, October 09, 2023--Cellistic reveals groundbreaking iPSC-based platforms to accelerate off-the-shelf allogeneic cell therapy development and manufacturing.
Ncardia and Cellistic recruit Gustavo Mahler to lead the businesses through their next phase of growth - read this article along with other careers information, tips and advice on BioSpace
Gosselies and Mont-Saint-Guibert, Belgium – Cellistic, the cell therapy development and manufacturing business of Ncardia BV, and Celyad Oncology (Euronext & Nasdaq: CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer, announced today
Latest updates on this topic from reliable sources.
Ncardia has launched a new business, Cellistic, to focus Ncardia's induced pluripotent stem cell (iPSC) expertise on the cell therapy development and manufacturing sector. This strategy expands on Ncardia's